Filed March 4, 2025

Serial No. 79422222

Registered Jan. 6, 2026

Registration No. 8,090,756

Class Pharmaceutical and biological preparations for the treatment of cancer and non-cancer fibrotic and inflammatory diseases for medical purposes; monoclonal antibodies for medical use; pharmaceutical preparations for the prevention, diagnosis and treatment of cancer and immune-mediated inflammatory and autoimmune diseases, namely tenosynovial giant cell tumor (TGCT), graft-versus-host disease, acute myeloid leukemia, chronic myelomonocytic leukemia, soft-tissue sarcoma, ovarian cancer, triple-negative breast cancer, head and neck cancer, malignant meningioma, T-cell lymphoma, osteosarcoma, glioblastoma, follicular lymphoma and malignant pleural mesothelioma; diagnostic reagents for medical purposes for use in connection with tenosynovial giant cell tumor (TGCT), graft-versus-host disease, acute myeloid leukemia, chronic myelomonocytic leukemia, soft tissue sarcoma, ovarian cancer, triple-negative breast cancer, head and neck cancer, malignant meningioma, T-cell lymphoma, osteosarcoma, glioblastoma, follicular lymphoma and malignant pleural mesothelioma; 005; 006; 018; 044; 046; 051; 052; 100; 101

Case Type Trademark Service mark